Skip to main content
Article
Evaluating non-hormonal therapy in a phase II trial of SM-88 for rising PSA prostate cancer.
Journal of Clinical Oncology (2019)
  • Benjamin Adam Gartrell, Albert Einstein College of Medicine
  • Giuseppe Del Priore, Morehouse School of Medicine
  • Avi S. Retter, Eastchester Center for Cancer Care, Bergenfield, NJ;
  • Wen-Tien Chen, Stony Brook University
  • Gerald H. Sokol, Florida Cancer Institute New Hope, Hudson, FL;
  • Alexander G Vandell, Tyme Inc, New York, NY;
  • Mack Roach, University of California, San Francisco
Publication Date
February 26, 2019
DOI
10.1200/JCO.2019.37.7_SUPPL.83
Citation Information
Benjamin Adam Gartrell, Giuseppe Del Priore, Avi S. Retter, Wen-Tien Chen, et al.. "Evaluating non-hormonal therapy in a phase II trial of SM-88 for rising PSA prostate cancer." Journal of Clinical Oncology Vol. 37 (2019) p. 83 - 83
Available at: http://works.bepress.com/gerald-sokol/4/